The atrial natriuretic peptide-renin-aldosterone system in hepatorenal syndrome

What Was Tested

The paper reports a study of ANP (Atrial Natriuretic Peptide), published as a clinical trial.

Aim of the study was to investigate the circulating plasma levels of the atrial natriuretic peptide (pANP), plasma renin activity (PRA) and plasma aldosterone (pA) in a group of HRS patients, compared to healthy controls.

Why It Was Studied

Hepatorenal syndrome (HRS) is a functional acute renal failure occurring in patients with advanced liver disease: the etiology of HRS is still unknown, but a role in its development and maintaining is played by the atrial natriuretic peptide-renin-aldosterone system.

Who Took Part

The study group was 20 patients.

PubMed indexes the participants as adults, middle-aged adults and older adults, both men and women.

Venous blood samples were drawn at 8:00 am in 36 healthy controls and in 20 patients with HRS following liver cirrhosis for the radioimmunoassay measurement of the circulating pANP, PRA and pA levels.

How the Study Was Run

The mean values of each variable were compared between the two groups by the "t" test; linear regression analysis was used to correlate the values of pANP and PRA, pANP and pA, and PRA and pA in the two groups.

What Was Measured

PubMed files the paper under topics including Aldosterone, Atrial Natriuretic Factor, Hepatorenal Syndrome, Renin and Renin-Angiotensin System.

What This Means in Plain Language

This is a clinical trial of ANP (Atrial Natriuretic Peptide) in 20 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.

The publication is from 1996 (Rivista europea per le scienze mediche e farmacologiche = European review for medical and pharmacological sciences = Revue europeenne pour les sciences medicales et pharmacologiques), a journal based in Italy.

More context: the ANP (Atrial Natriuretic Peptide) compound page, all human trials.